MRI Media Approved for Use with Power Injection

 

June 6, 2006

Offering a selection of packaging options and concentrations (160, 240, 300, 320 and 350), OptiMARK (gadoversetamide injection) is one of the first MRI contrast agent approved for use with power injection. Using OptiMARK with the OptiStar LE power injector at rates of 1 to 2 ml per second image quality, diagnostic accuracy, reproducibility, accurate timing of bolus and a tight bolus (when used with saline flush at the same flow rate as the contrast media), said Tyco. It is available in glass vials in a range of sizes or easy-to-use Ultraject prefilled syringes.